Antiviral T cells safe, effective as off-the-shelf therapy for painful complication after stem cell transplants
Antiviral T cells safe, effective as off-the-shelf therapy for painful complication after stem cell transplants A Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center found that BK virus (BKV)-specific T cells from healthy donors were safe and effective as an off-the-shelf therapy for BKV-associated hemorrhagic cystitis (BKV-HC), a painful complication common after allogeneic stem cell transplants for patients with leukemia or lymphoma. The study was published today in the Journal of Clinical Oncology. Infusion of T cells targeting BKV resulted in rapid resp...